From May to July 2024, multiple medical enterprisesExecutive Changes Occur.
Thermo Fisher Scientific AnnouncesMiguel Faustino, current President of Chemical Analysis Business at Thermo Fisher's Analytical Instruments Division, will assume the role of President of Thermo Fisher China from August 1, 2024, succeeding Hann Pang.Mr. Miguel Faustino joined Thermo Fisher Scientific in 2013. During his tenure, he has held several global senior leadership positions, demonstrating his pursuit of continuous excellence with tangible achievements. He has led his team to significant business success and achieved expansions in multiple related fields. Mr. Miguel Faustino holds a bachelor’s degree from Boston College and a Master of Business Administration from the MIT Sloan School of Management.Johnson & Johnson announced that Zhou Mintao will assume the role of President of its MedTech China region starting July 25, 2024, reporting to Vishnu Karla, Chairman of the Asia-Pacific region. With nearly 30 years of experience at Johnson & Johnson, Zhou Mintao has driven business growth and innovation across various leadership positions. He also previously...Served as the President of Greater China for Cytiva, a biotechnology company under Danaher, and successfully integrated Pall Science. His diverse industry experience and deep insights into the healthcare sector have earned him high recognition in the industry.BGI Genomics Co., Ltd. announced that due to the expiration of his term, Yin Ye, Vice Chairman of the Third Board of Directors, will no longer serve as Vice Chairman, Non-Independent Director, and Audit Committee Member. However, he will continue to serve as a director of some of the company's holding subsidiaries. As of the date of the announcement, Yin Ye directly holds 1,064,000 shares of BGI Genomics.GE Healthcare announced the appointment of Roland Rott as President and CEO of Imaging, and Phil Rackliffe as President and CEO of Ultrasound and IGT (Image-Guided Therapy). The appointments took effect on July 1.Prior to this promotion, Mr. Roland Rott was the President and Chief Executive Officer of GE Healthcare's Ultrasound Division.Philip Rackliffe is the current President and Chief Executive Officer of IGT.Danaher Corporation announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis as Executive Vice President of Diagnostics, effective July 1, 2024. Sawyer Montgomery joined Danaher in 2017. In her current role, she is responsible for providing strategic leadership to Danaher's diagnostics business. She previously served as President of Beckman Coulter Diagnostics. Before joining Danaher, Sawyer Montgomery held leadership positions at Hospira Infusion Systems, Boston Scientific, and Boston Consulting Group.Illumina Announces Appointment of Everett Cunningham as Chief Commercial Officer (CCO), Effective June 10. Prior to joining Illumina, Mr. Cunningham served as Chief Commercial Officer at Exact Sciences, where he was responsible for the company’s marketing, sales, and customer service functions. Mr. Cunningham brings extensive experience in the healthcare industry, having held various senior leadership roles at renowned healthcare companies such as Quest Diagnostics, GE Healthcare, and Pfizer.Wondfo Biotech Held the 29th Meeting of the Fourth Board of Directors, Nominating Ms. Wang Jihua, Mr. Peng Zhongxiong, Mr. Zhao Yaping, and Mr. Li Dali as Non-Independent Director Candidates for the Fifth Board of Directors. Li Dali, born in 1996, graduated with a dual bachelor’s degree in accounting and finance from the University of Illinois at Urbana-Champaign in 2018 and obtained a master's degree in accounting and fundamental analysis from Columbia Business School in 2019. From 2020 to 2021, he served as an investment analyst at C-Bridge Capital; in 2022, he joined Wondfo Biotech as the Shanghai Regional Manager of the Domestic Marketing Quantitative Department, and currently serves as the company's Strategic BD Director and head of the Dry Chemistry and HbA1c product lines. Mr. Li Dali is the son of Ms. Wang Jihua, the company’s Chairwoman and actual controller, and the son of Mr. Li Wenmei, a director and actual controller of the company.United Imaging HealthcareUnited Imaging Healthcare Announces Resignation of TAO CAI, CFO and Chief Financial Officer. 2016-2020,TAO CAI Served as Senior Vice President and Chief Investment Officer of United Imaging Healthcare; from 2020 to 2022, served as Board Secretary and Chief Investment Officer of United Imaging Healthcare. He has also held positions in companies such as Kodak (China) Co., Ltd., Vimicro Corporation, First Energy Systems Co., Ltd., and China Biologic Products Holdings, Inc. Meanwhile, the company agreed to appoint Mr. Wang Jianbao as the company's Financial Director and Chief Financial Officer.Source: CACLP Comprehensive Arrangement
Editor: As素 | Proofreader: 咸鱼 | Responsible Editor: 木霖森Submission Email:tougao@caivd-org.cn
① The final interpretation rights and copyrights of the original content published by this official account are owned by ZhiAoRuiHe (Shanghai) Exhibition Co., Ltd. For reprinting, please indicate the source as "CACLP In Vitro Diagnostics Information" at the beginning of the article, and enter "reprint" in the information column to obtain reprint guidelines. ② Articles sourced from other publications on this official account are reprints and do not represent the views or positions of this platform. ③ Media cooperation: 021-52258212
